Business Context and Reporting Period
This Form 8-K is a current report filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on December 27, 2014. The filing addresses a change in executive leadership effective January 1, 2015.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and employment agreements.
Material Changes
- Executive Role Change: Kimble L. Jenkins, currently the Chief Executive Officer, will transition to the role of Chairman of the Company effective January 1, 2015.
- Employment Agreement: A new employment agreement was entered into on December 27, 2014, to formalize this role change. Terms remain consistent with his prior agreement filed in June 2012, except for the change in capacity.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. The document is limited to the disclosure of the executive appointment and the attached employment agreement.
Investor Verification Checklist
- Verify the effective date of the CEO to Chairman transition (January 1, 2015).
- Confirm the appointment of a new Chief Executive Officer to replace Mr. Jenkins.
- Review the full text of the Employment Agreement (Exhibit 10.1) for specific compensation details.
- Check subsequent filings for the announcement of the new CEO.